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AN EPIDEMIOLOGIC STUDY OF LEUKEMIA 
IN OKLAHOMA, 1961-1965
CHAPTER I
INTRODUCTION AND REVIEW OF LITERATURE
Leukemia as a definitive disease has a history of 
little more than one hundred years. It was first described 
by Velpeau (126) in 1827 when he described the blood of a 
deceased patient as being thick, "like gruel . . . resem­
bling in consistency and color the yeast of red wine.
. . . One might have asked if it were not rather laudable
pus, mixed with blackish coloring matter, than blood." It 
was the appearance of the blood which first attracted the 
attention of early students of the disease. Barth (10) 
examined the blood microscopically. Donne (2) also examined 
leukemic blood by microscope and described "mucous globules" 
which could not be distinguished from pus corpuscles.
Bennett (13) and Virchow (129) recognized leukemia 
as a definite disease entity in simultaneous, independent 
publications in 1845. In 1852 Bennett published a monograph 
on "Leucocythaemia" in which he described thirty-seven
cases, seventeen of which had been diagnosed during life by 
means of blood examinations. Virchow during that time pub­
lished a series of studies on the disease, introducing the 
term "leukemia."
In the century that has elapsed since the studies 
of Bennett and Virchow, progress has been made in the diag­
nosis, classification, and descriptive pathology of 
leukemia. Advances in therapy, including antibiotics, 
blood products, and chemotherapeutic agents, have resulted 
in prolonging life from weeks or months to several years in 
many leukemia patients. But the causes of leukemia remain 
obscure. Certain relatively consistent relationships have 
been established between leukemia and a number of proposed 
etiologic agents (51). It is well documented that exposure 
to ionizing radiation is associated with an increased risk 
of developing certain types of leukemia (14, 19, 24, 28,
56). Fairly convincing evidence has implicated benzene in 
human leukemia (32). Several other chemical agents, 
including some drugs, are suspect (12, 18, 34). The role 
of viruses in the development of leukemia in certain 
strains of laboratory rodents is well documented (3). 
Viruses are known to be implicated in many hyperplastic 
lesions in laboratory animals and in humans (3, 19). Evi­
dence exists that suggests a virus may play a role in the 
development of human leukemia (95). Unusually large num­
bers of cases of leukemia have been noted to occur within
limited geographic areas in short periods of time, suggest­
ing the possibility of an infectious agent (65, 85). Viral 
particles have been observed in electron micrographs of 
tissues from patients with leukemia and related malignancies 
(67). The geographic distribution of a similar malignant 
reticulosis, Burkitt's Lymphoma in Africa, suggests a pos­
sible vector dependent on specific climatic conditions and 
therefore suggests an infectious agent (20). The finding 
of a herpes-type virus in tissue homogenates and in serum 
of patients with Burkitt's Lymphoma further suggests a viral 
etiologic agent (38, 67). Videbaek (127), Heath (63), 
Anderson (7) and others have noted unusual familial aggre­
gations of leukemia wherein a number of cases have occurred 
greatly exceeding the expected incidence and strongly sug­
gesting a genetic mechanism or predisposition to the 
disease. Attempts to demonstrate excessive familiality in 
instances outside these unusually affected families have 
met with little success. Videbaek (5) noted an excessive 
incidence of leukemia, other cancers, and pernicious anemia 
in relatives of leukemic patients. However Videbaek's con­
trols have been severely criticized, and most investigators 
have been unable to confirm his findings. Leukemia has 
been observed in well documented association with Down's 
Syndrome or Mongolism (94) and with other demonstrable 
chromosome abnormalities (87, 97). Sandberg, et al. (109, 
110, 111) have consistently observed chromosome
abnormalities in peripheral blood and bone marrow prepara­
tions of patients with leukemia. Opinions differ as to 
whether this aneuploidy predisposes to, or is a product of, 
the leukemic process. The role of heredity in the develop­
ment of human leukemia is still unclear.
The present paucity of knowledge concerning the
etiology of leukemia is similar to that of 1938 which
prompted Forkner (43) to observe that
. . . almost nothing is known of the causes, either
immediate or remote, of leukemia. In a minority of 
cases some disease or incident can be found in the 
patient's life to which the leukemia is sequential 
in time and to which, in some degree, it may be 
related. In the majority of cases no such anteced­
ent is demonstrable. Those etiologic conditions 
which can be traced or suspected in some cases 
stand in a position with relation to the disease 
which is too uncertain to allow them to be con­
sidered as exciting or predisposing causes.
Of all basic and clinical research being concentrated in 
this area at the present time, carefully designed and well 
executed epidemiologic studies hold a place of prime impor­
tance in describing potential etiologic relationships and 
directing other research efforts into more fruitful areas 
of endeavor.
Mortality rates for leukemia over the past twenty 
years in the United States indicate consistent increases in 
the occurrence of this disease (52). Some of this increase 
has been attributed to improved methods of diagnosis, 
advances made in the scope of disease certification, and 
improved therapeutic handling and resultant survival of
cases beyond the preleukemic phase with its tendency to 
infections and bleeding. However, the magnitude of the 
increase in death rates indicates more than improved detec­
tion and registering of cases, and is profoundly suggestive 
of increased exposure of the population to leukemogenic 
factor? (44). In the United States the death rate from 
leukemia among males increased from 4.4 per 100,000 popula­
tion in 1940 to 7.5 per 100,000 in 1960, and among women, 
from 3.1 in 1940 to 4.9 in 1960. Although all age groups 
have experienced consistently rising rates, the increase 
has been especially high in middle age and older individ­
uals. For example, in men over fifty years of age, the 
death rate increased from 10.9 per 100,000 in 1940 to 22.6 
per 100,000 in 1960, and for women over fifty years of age, 
from 7.4 per 100,000 in 1940 to 13.9 in 1960. After 1940, 
mortality statistics in the U.S. revealed the beginning of 
an age peak at 3 and 4 years that increased with time in 
U.S. whites, but which did not appear in U.S. non-whices. 
More recently, however, a peak has begun to appear at the 
age of 4 years in non-whites. This has been interpreted as 
an indication of "delayed exposure" of U.S. non-whites to 
some environmental leukemogen (26, 44, 52).
Often thought of as primarily a child's disease, 
leukemia kills more adults than children. White persons 
have a 50% greater risk of dying of leukemia than do 
negroes, and the disease is markedly more prevalent among
families of higher income. The Jewish people have a rela­
tively low incidence of most forms of cancer but have an 
inordinately high incidence of leukemia (44, 54).
Recent observations by Fraumeni and Miller (44) con­
cerning mortality statistics have, for the first time, shown 
a downturn in leukemia death rates in all ages from 1 to 74 
years among the U.S. white population, but not among the U.S. 
non-white population, nor in England. While the decline has 
affected all ages between 1 and 74 years, it is most pro­
nounced among children 1-4 years of age. It is yet too soon 
to say whether this downturn indicates a leveling off of the 
increases seen in leukemia mortality rates over the past 
several decades, or whether it is merely a random fluctua­
tion in mortality patterns. In spite of the recently 
reported downturns in leukemia death rates, deaths from 
leukemia are still increasing each year among all age 
groups and races, and in both sexes (26, 44).
In marked contrast to the generally uniform distri­
bution of leukemia cases in time and space, curious 
"clusters" of cases have been observed in which an unusually 
large number of leukemias occur within a small geographic 
area during a short period of time (85). Recently reports 
have come from Cheyenne, Wyoming; Niles, Illinois; Bergen 
County, New Jersey, and elsewhere of incidence levels of 
leukemia far above the expected (64, 65, 66). These 
spatial and temporal aggregations provide the analytic
epidemiologist a unique opportunity to study the disease 
within the environment which may have played a role in its 
genesis. Many workers feel that leukemia clusters indicate 
a high level of one or more leukemogenic factors in the 
environment, perhaps an infectious agent, and hence provide 
an unusual opportunity to identify and study these factors. 
The "cluster phenomenon" is given particular attention by 
proponents of the hypothesis that a viral or other infec­
tious agent is implicated or responsible in the etiology 
and transmission of human leukemia (121) . A number of 
investigators have suggested the possible etiologic role of 
viruses in human leukemia (65, 95). That viruses cause 
leukemia in a number of animal species is now well estab­
lished (116). Recently, seroepidemiologic studies have 
revealed an association between antibodies to certain 
viruses and the occurrence of leukemia (67). These discov­
eries suggest the possibility of a causal relationship 
between certain filterable agents and leukemia in man.
In many instances however, leukemia "clusters" tend 
more to reflect: 1) the irregularity that is often observed
with rare diseases and small numbers of cases; 2) after the 
fact drawing of time and space boundaries which serve to 
accentuate the grouping of cases; 3) exhaustive attempts to 
locate cases of leukemia in the suspected area compared to 
less complete reporting in neighboring areas; and, 4) vari­
ability in population density, migration, and race
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distribution. Even in the more dramatic examples, as in 
Niles, Illinois, where eight cases of childhood leukemia 
were observed between September, 1957, and August, 1960, in 
a population of approximately 7,000 children, the aggrega­
tion may not indicate transmission by an infective agent, 
nor excessive concentrations in the environment of 
leukemogenic factors, but may instead be an unusual phenom­
enon which could occur by chance (66, 37, 53).
If environmental factors are responsible for leuke­
mia trends, these factors should increase or decrease 
concomitantly with changes in leukemia death rates. Such 
is not the case with ionizing radiation. Sir'.e radiation 
can induce acute leukemia or chronic myelogenous leukemia, 
but not chronic lymphatic leukemia, and since there is a 
linear relationship between radiation dosage and incidence, 
one would expect the decrease in per capita exposure over 
the past decade to be reflected in leukemia mortality rates 
(28). A study of leukemia mortality by cell types should 
also indicate whether recent trends are attributable to the 
decreasing exposure to radiation. However, a study of these 
data does not support the hypothesis that the declining mor­
tality is correlated with radiation exposure. Several other 
comparisons of mortality trends and exposure to environmen­
tal factors have been equally unrewarding. However, because 
leukemia clusters may reflect unusual environmental factors,
continued study and investigation may yet yield important 
epidemiological information (35, 53).
CHAPTER II 
METHODS
The purpose of this study is to determine the inci­
dence and distribution of leukemia in Oklahoma for the 
period January 1, 1961, through December 31, 1965, and to 
carry out controlled descriptive studies in areas charac­
terized by sharply elevated incidence, hereafter referred 
to as "cluster areas." The "cluster area" has been arbi­
trarily defined as any county in the state whose five year 
average mortality or incidence rate is greater than twice 
the national average of seven cases per 100,000 population 
per year, or whose mortality or incidence rate exceeds 
twice the national average for any single year when, in 
addition, striking temporal and spatial case-clustering 
occurs within the county unit.
Annual mortality from leukemia closely approximates 
the incidence of the disease. This approximation is of 
course greater with time since all cases eventually die. 
Since mortality records are relatively complete in their 
coverage of all deaths from this cause, mortality is used 
in this study as one estimate of leukemia incidence.
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Mortality data was supplied by the Statistics Division of 
the Oklahoma State Department of Health. This information 
was analyzed by sex, race, age, clinical and/or patholog­
ical diagnosis, county of residence and year of diagnosis. 
This data is of relatively good quality due to near univer­
sal registry of leukemia deaths.
The ability of mortality information to estimate 
true incidence is limited by several factors. Mortality 
data, while including virtually all cases occurring, often 
gives little or no information as to the time of onset, or 
the place of residence of the patient at onset. Incidence 
estimated by mortality does not include leukemia cases 
still living. In that leukemia is a universally fatal 
disease, with death usually occurring within a very few 
months or years from onset, these limitations are somewhat 
minimized. Data obtained through examination of death 
registration certificates are usually accurate and complete 
with regard to age, sex, race, residence, clinical diagno­
sis, immediate cause of death, and secondary causes and 
complications. The number of cases of leukemia missed in 
death registration data is small. But it is clear that 
mortality data leave much to be desired in pinpointing the 
occurrence of cases in time and space, making it difficult 
to determine the occurrence of elevated incidence and to 
correlate elevated incidence with possible etiological 
factors.
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To obtain the additional information needed to 
determine the incidence and distribution of leukemia, hos­
pital records of leukemia cases occurring in Oklahoma 
during the study period were examined. Examination of 
medical records yields valuable information such as age, 
date and residence at onset, medical and/or pathological 
diagnosis, clinical data and background information which 
might be of epidemiologic importance. This information 
permits the formulation of reasonably accurate incidence 
statistics unobtainable from mortality data due to the vari­
ability in the period of time elapsing between diagnosis and 
death, and the relocation of the patient from one to another 
geographic area. Leukemia is particularly amenable to this 
type of study since virtually all cases require hospitaliza­
tion in facilities of size and quality sufficient to cope 
with the myriad of therapeutic problems encountered. Some 
leukemia cases may, however, escape detection. A young 
patient, in acute leukemic crisis, might expire before 
definitive diagnosis was made and not be autopsied. The 
aged person in the terminal stages of a more immediately 
life threatening disease, or a case with bizarre manifesta­
tions might evade diagnosis. Hospital record data is nec­
essarily dependent upon the accuracy and completeness of 
the medical records examined and upon the ability of the 
hospital to retrieve all such records. Some cases are 
missed because of referral to famous specialty treatment
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facilities in other states. Other patients, especially 
those in the extreme northwestern and southeastern sectors 
of Oklahoma, may seek medical attention in facilities in 
neighboring states.
The medical records of Oklahoma hospitals accred­
ited with the Joint Committee on Accreditation of Hospitals 
(JCAH) were examined to obtain the incidence information 
utilized in this study. Because of the uniform geographic 
distribution of these fifty-two hospitals across the state, 
the superiority of their records systems in terms of con­
tent and retrieval capability, and the practice of 
hospitalization of leukemia patients in large, more modern 
facilities for care, this method is considered reliable for 
obtaining reasonably thorough coverage of the Oklahoma 
leukemia population. Permission was obtained from the 
administrators of each of these hospitals to examine their 
medical records; each administrator was notified prior to 
the arrival of the investigators and was requested to 
retrieve the records of all leukemia patients hospitalized 
from 1961 to 1965. Each record was examined and informa­
tion regarding name, age, sex, race, address, date of 
onset, clinical and pathological diagnosis and other perti­
nent information (e.g. history of exposure to insecticides, 
radiation; other cases of leukemia or other cancers in 
immediate family, congenital abnormalities, and previous 
illnesses was recorded). The Case Record Form in Appendix A
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was used for recording this information. This information 
was later coded and transcribed to data processing cards 
which were filed by Hill-Burton area, by county, by year of 
diagnosis, and by name. Filing by name prevented duplica­
tion of cases treated in more than one hospital.
Since the county unit often provides a population 
base too small for a completely satisfactory study of a 
disease with a low incidence rate, such as leukemia, a 
larger population unit was used in addition to counties.
The ten regions defined by the Hill-Burton program for hos­
pital construction have been used since they 1) utilize 
existent county boundaries, 2) are comprised of a number of 
counties representing definite geographic areas with common 
economic, trade, and other characteristics, 3) have at 
least one general hospital of not less than 100-bed capac­
ity, and a sufficiency of related health facilities for the 
central city to assume the characteristics of a medical 
center, and 4) provide a population base of sufficient size 
for more meaningful rate calculation. Complete descrip­
tions of these ten regions are included in Appendix C.
The data obtained from the examination of mortality 
statistics and medical records of leukemia patients were 
used to compute mortality and incidence rates for the 
seventy-seven counties, the ten regions, and for the state. 
Age adjusted mortality and incidence rates were computed 
for the state for the five year period; and age, race, and
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sex specific rates were computed for the ten regions by 
year. These rates have been analyzed and compared, and 
regions of elevated mortality and incidence examined for 
unusual age, sex, or race composition and distribution.
Counties with elevated incidence have been studied 
in depth. Descriptive profiles were constructed including 
pertinent information regarding geographic characteristics, 
mineral and other geological aspects, description of vegeta­
tion and animal life (domestic and wild), meteorological 
variables and climate, economical and social parameters, 
occupation data, health status (mortality and morbidity 
experience), and medical resources. (See Appendix C.) In 
addition, an interview with a member of the patient's family 
was conducted. A Case Investigation Form (Appendix B) 
designed to extract epidemiological information concerning 
the patient's personal and social history, environment, 
medical history, and other factors possibly associated with 
his leukemia, was completed.
The complete profiles of leukemia patients from 
within the cluster areas were compared with 1) case profiles 
of apparently normal, non-leukemic controls from within the 
cluster areas, matched for age, sex, and race; 2) case pro­
files of leukemia patients from matched non-cluster areas; 
and 3) case profiles of apparently normal, non-leukemic con­
trols from non-cluster areas, matched for age, sex, and 
race with non-cluster area leukemia cases. Information
16
concerning the four groups studied was compared for differ­
ences in pertinent epidemiological factors. These 
differences will be discussed later and related to possible 
etiologic determinants. Factors responsible for such dif­
ferences will be discussed relative to sampling errors, 
chance, or true differences in the environment which might 
affect the incidence and distribution of the disease. The 
methods used in this study were developed and tested in a 
pilot study in Hughes County, Oklahoma.
CHAPTER III 
R E S U L T S
Oklahoma's annual leukemia mortality rates have 
been slightly higher than the national average throughout 
the 1961-1965 period. The average five-year crude rate 
for Oklahoma, 1961-1965 was 8.5 deaths per 100,000 popu­
lation per year. The age-adjusted rate was 7.9 per 
100,000 per year. Figure 1 shows Oklahoma and U.S. rates 
for the 1961-1965 period. Oklahoma rates are slightly 
higher than the U.S. rates and show an increase over the 
five-year period, whereas U.S. rates have remained approx­
imately the same. The effect of age-adjustment (direct 
method) in lowering state mortality rates is demonstrated 
also.
Figure 2 and Table 1 show mortality from respec­
tive types of leukemia. Acute leukemia is observed most 
frequently in all years except 1963. The over-all trend 
for acute leukemia and chronic lymphocytic leukemia is a 
gentle increase over the five-year period. The other 
types do not show this increase. Perhaps the most inter­






















Fig. 1.--Oklahoma and U.S. mortality 
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Fig. 2.--Leukemia mortality by year 
and by type in Oklahoma, 1961-1965.
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TABLE 1














1961 59 45 34 17 29 184 7.5
1962 63 48 47 21 15 194 7,9
1963 57 58 31 21 25 192 7.4
1964 73 68 28 11 23 203 7.8
1965 79 63 38 23 30 233 9.1
Total 331 282 178 93 122 1006^ 7.9
&Age-adjusted mortality rate (per 100 ,000) .
bpou c cases o f unspecified diagnosis omitted
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difference between chronic lymphocytic leukemia and 
chronic myelocytic leukemia with time. In 1961 and 1962 
chronic lymphocytic leukemia and chronic myelocytic leu­
kemia accounted for about the same number of deaths, but 
in 1963 a divergence began that resulted in a difference 
of 40 more chronic lymphocytic leukemia deaths than 
chronic myelocytic leukemia deaths in 1964. The differ­
ence was slightly less in 1965. The over-all trend, as 
noted in Figure 1, is an increase in the number of deaths 
from all types of leukemia. Most of this increase is 
attributable to acute leukemia and chronic lymphocytic 
leukemia.
Figure 3 and Table 2 show leukemia mortality by 
age groups and by year. The 5-44 age group has the lowest 
mortality. The 5-14, 15-24, 25-34, and 35-44 age groups 
have been combined to simplify the figure, since mortality 
is uniformly quite small in them. Though no clear trend 
is observed in these data, the 65-74 and 75 and over age 
groups both show rather sharp increases in 1965 over 1964. 
They appear to account for a large part of the mortality 
excess observed in 1965. Below 54 years of age the rates 
appear very stable.
Table 3 shows yearly mortality by sex and race. 
Examination of the upper part of the table shows that 
males contributed slightly more to the increases in mor­
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Fig. 3.--Leukemia mortality by age 
groups and by year in Oklahoma, 1961-1965.
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TABLE 2
OKLAHOMA LEUKEMIA MORTALITY BY
AGE GROUPS , 1961- 1965
Age 1961 1962 1963 1964 1965 Total
Under 5 10 10 8 11 11 50.
Rate^ 4.1 4.1 3.7 4.5 4.5 4.2°
5-14 # 10 13 22 12 14 71
Rate 2.1 2.7 4.6 2.5 2.9 3.0
15-24 # 7 8 7 2 7 31
Rate 2.1 2.4 2.1 . 6 2.1 1.9
25-34 # 4 4 2 7 5 22
Rate 1.4 1.4 .7 2.6 1.5 1.5
35-44 # 9 9 7 7 8 40
Rate 3.4 3.1 2.4 2.4 2.8 2.8
45-54 # 14 16 12 19 20 81
Rate 5.1 5.8 4.3 6.7 7.4 5.8
55-64 # 29 35 29 46 33 172
Rate 3.5 16.0 12.7 19.4 14.0 15.1
65-74 # 45 42 48 46 56 237
Rate 29.3 26. 3 29.6 28.5 39.5 30.6
75 & up # 56 58 58 54 80 306
Rate 66.9 59.9 58.4 56.0 77.6 63.8




OKLAHOMA LEUKEMIA MORTALITY BY RACE, 















races 7.9 185 8.3 194 8.2 193 8.7 206 9.9 234
Male 9.1 105 10.2 118 10.8 125 10.7 125 11.9 139
Female 6.8 80 6.4 76 5.7 68 6.8 81 7.9 95
White 8.2 176 8.4 182 8.2 180 8.5 188^ 9.6 216
Male 9.5 99 10.5 110 11.0 116 10.9 115 11.8 117
Female 7.2 77 6.7 72 5.9 64 6.7 73 8.4 91
Non­
white 4.2 9 5.6 12 5.9 13 6.4 14 8.1 18
Male 5.6 6 7.4 8 8.3 9 9.2 10 12.8 14




races 1. 35 1. 55 1.84 1. 54 1.46
White 1. 26 1. 53 1.81 1. 58 1.37
Non­
white 2. 00 2. 00 2.25 2. 50 3.50
^Rates per 100,000.
^One case omitted for reason of race unknown. 
^Ratio of male to female cases.
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the whites and non-whites experienced consistent increases 
in mortality, although non-white rates increased slightly 
more than did white rates. Non-white males account for a 
small number of cases, but their rate more than doubles 
from 1961 to 1965.
Figure 4 shows age-specific mortality rates for 
the nine age groups. The small peak observed in the 
younger ages decreases with each older age group until 
reaching its lowest point in the 25-34 age group. The 
mortality rates then increase with each succeeding age 
group.
Leukemia mortality by age group and by type is 
illustrated in Figure 5. Acute leukemia makes up a large 
proportion of the cases in the first four age groups. It 
reaches its lowest point in the 25-34 age group and then 
begins an ascent that continues throughout life, with the 
possible exception of a slight downturn in the 75 and 
older age group. Mortality from chronic lymphocytic leu­
kemia is low in the age groups under 45 but then begins an 
increase that becomes very sharp in the 45-54 age group. 
This increase continues thereafter. Chronic myelocytic 
leukemia mortality is about the same as that of chronic 
lymphocytic leukemia up to the 25-34 age group, but then 
exceeds mortality from all types (except acute leukemia) 
up to age group 55-64 where chronic lymphocytic leukemia 












under 5- 15- 25- 35- 45- 55- 65- 75 &
5 14 24 34 44 54 64 74 up
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Fig. 4.— Age-specific leukemia 























under 5- 15- 25- 35- 45- 55- 65- 75 &
5 14 24 34 44 54 64 74 up
AGE
Fig. 5.--Leukemia mortality by age and 
by type in Oklahoma, 1961-1965.
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a steady increase until the 75 and older age group where 
it levels off. Monocytic and monoblastic leukemia are 
relatively rare until age 45, showing rather sharp 
increases thereafter, and leveling off about the 65-74 age 
group. Atypical and aleukemic leukemia account for a peak 
of cases in the 5-14 age group and then another peak 
beginning in the 45-54 age group reaches its maximum 
height in the 75 and older age group. After 74 years of 
age, aleukemia and atypical leukemia account for more 
deaths than chronic myelocytic leukemia.
The classification of leukemia types used in mor­
tality data differs from the system used for incidence 
data in the following section, requiring caution in point 
comparisons of the two sets of information. It is not 
known with certainty how many cases of acute aleukemic 
leukemia are placed in the "acute" versus "aleukemic" 
categories. Neither is it known how many cases of acute 
monocytic or monoblastic leukemia are placed in the 
"acute" versus "monocytic-monoblastic" categories. The 
most comparable items in the two sources of data are acute 
leukemia, chronic lymphocytic leukemia, and chronic 
myelocytic leukemia. Acute leukemia mortality and inci­
dence are closely comparable between the ages of 15 and 
44 since monocytic and monoblastic leukemia are so rare 
in these ages.
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Figure 6 shows age-, race-, and sex-specific 
mortality rates. Leukemia risk increases with age for 
both sexes in whites and non-whites. The increase is most 
noticeable in the last two age groups, particularly among 
white males. White females and non-white males occupy an 
intermediate position and encounter essentially identical 
risks of developing leukemia, whereas non-white females 
experience a relatively low risk.
Figure 7 shows Oklahoma leukemia mortality com­
pared with leukemia incidence as determined by the study 
of hospital records, for 1961-1965. Incidence, as 
measured:by the hospital records study, is 75.5% of the 
registered leukemia mortality for the same calendar 
period. The low incidence observed in 1962 will be dis­
cussed later. The five-year incidence trend does not 
demonstrate increases comparable to those observed for 
mortality during the same period.
Figure 8 shows the relative contribution of the 
different types of leukemia, acute, chronic lymphocytic, 
chronic myelocytic, and other and non-specified types. 
Acute leukemia shows a net increase and chronic myelocytic 
a net decrease over this period, but the other two types 
show no obvious trend. Acute leukemia is the most fre­
quently observed type throughout the study period, chronic 
lymphocytic is second, chronic myelocytic third, and other 
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Fig. 6.— Leukemia mortality by age,
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Fig. 7.--Comparison of Oklahoma 
mortality and incidence^ from leukemia, 
1961-1965.
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Fig. 8.--Leukemia incidence by year and 
by type in Oklahoma, 1961-1965.
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variation in the proportion of each type from year to 
year, but the above order of frequency is consistent 
through the five-year period.
Regarding the small number of cases observed in 
1962 in Figure 7, examination of Figure 9 shows sharp 
decreases in leukemia incidence in the 65-74 and 55-64 age 
groups and a slight decrease in the 45-54 age group in 
1962. Examination of Figure 8 shows a sharp decrease in 
1962 in chronic myelocytic leukemia, the most common type 
of leukemia in the 55-64 and 65-74 age groups (26).
Figure 2 shows that this decrease is not reflected in 
chronic myelocytic leukemia mortality in 1962, but that 
substantial decreases in chronic myelocytic leukemia mor­
tality did occur in 1963 and 1964. Figure 8 also shows 
smaller decreases for acute leukemia and for other non- 
specified types in 1962. The combination of decreases had 
a measurable effect upon the 1962 total. Figure 9 and 
Table 4 show that the age, sex, and race composition of 
the leukemia population in 1962 is not greatly different 
than in the other four years.
Figure 9 shows leukemia incidence by age groups 
throughout the study period. The highest incidence occurs 
in persons 75 years of age and older, and the lowest inci­
dence in persons between 5 and 44.
Table 4 shows leukemia incidence by race and sex. 
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Fig. 9.--Leukemia incidence by year
and by age in Oklahoma, 1961-1965.
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TABLE 4
















races 6.5 154 5.5 132 6.7 162 6.3 155 6.5 162
Male 6.5 99 6.6 78 8.7 104 6.9 84 6.9 97
Female 4.6 55 4.4 54 4.7 58 5.7 71 5.1 65
White 6.7 144 5.8 125 7.1 156 6.7 149 7.1 159
Male 8.6 91 6.7 72 9.3 101 7.5 82 8.5 94
Female 4.9 53 4.8 53 4.9 55 5.9 67 5.7 65
Non­
white 4.4 10 3.0 7 2.6 6 2.5 6 1.2 3
Male 7.3 8 5.4 6 2.7 3 1.7 2 2.6 3




races 1. 80 1. 44 1. 79 1. 18 1.49
White 1. 72 1. 36 1. 34 1. 22 1.45
Non-
white 4, DO 6. DO 1. DO 0. 50
1-----------
^Rates per 100,000.
^Male cases to female cases.
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figures, and among males it is more common in whites.
White females experience greater incidence on the average 
than non-white males, though the latter had higher rates 
in 1961 and 1962. Non-white females have the lowest rates 
of all. The sex ratios observed in the lower part of 
Table 4 illustrates the increased risk of leukemia in males 
of both races. The difference in rates for white males 
between 1962 and 1963 is significant at the .05 level.^
The difference in rates for non-white males between 1961 
and 1964 is also significant at the .05 level.^
Figure 10 illustrates age-specific incidence rates 
for 1961-1965 in Oklahoma. A bimodal distribution is 
observed here, although the peak in the under 5 age group 
is small.
Figure 11 shows leukemia incidence by type and by 
age. The peak noted in the younger ages is almost 
entirely the result of acute leukemia. Chronic leukemia 
makes up a very small proportion of cases up to age 45.
In the middle age groups where the incidence of all leuke- 
mias is lowest, acute leukemia makes up about half of all
significance test comparing the difference 
between two rates was utilized where the Standard Error 
was determined by the formula:
S.E. =
N Ui n^
n ̂  and n^ refer to the numbers of cases of leukemia used
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Fig. 10.--Age-specific leukemia 
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Fig. 11.— Leukemia incidence by age
and by type in Oklahoma, 1961-1965.
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cases. In the 45-54 age group chronic lymphocytic leuke­
mia is approximately equal to acute leukemia and continues 
to increase with age, being the most prevalent type after 
age 54. All types increase with age up to about 70.
During the 65-74 age group, acute leukemia and chronic 
myelocytic leukemia begin to show decreases in incidence, 
whereas chronic lymphocytic leukemia continues its steep 
increase. Chronic myelocytic and acute leukemia have very 
similar incidence in the 35-44 age groups. They separate 
shortly afterward with acute leukemia becoming the more 
common type on into old age.
Figure 12 illustrates age, race, and sex specific 
incidence rates for leukemia. White males have the high­
est incidence of leukemia from birth to death. White 
females are consistently lower throughout life, and non­
white males and females are still lower. The unusual 
pattern noted in non-white females in the last two age 
groups is the result of a very small number of cases used 
in the construction of the rates. The white versus non­
white difference is most marked in middle age.
Oklahoma leukemia mortality examined by Hill- 
Burton Regions exhibits the pattern seen in Figure 13 and 
Table 5. Complete descriptions of the Hill-Burton Regions 
are contained in Appendix C. Leukemia incidence for these 
regions appears in Figure 14 and Table 6. None of these 
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Area-□■ 7.0 to 8.4 per 100 8.5 to 9.9 per 100,000
10.0 per 100,000 and greater
Fig. 13.— Geographic distribution of 
leukemia mortality in Oklahoma, 1961-1965.
TABLE 5
LEUKEMIA MORTALITY RATES FOR THE 
TEN HILL-BURTON REGIONS IN 
OKLAHOMA, 1961-1965^
Region 1961 1962 1963 1964 1965 AverageAnnual
1 8.6 7.3 6.3 9.5 10.4 8.4
2 11.4 6.4 12.7 10.5 4.8 9.2
3 11.3 10.7 8.7 13.2 14.8 11.7
4 6.1 12.3 13.2 5.1 13.9 10.1
5 7.8 7.8 7.7 6.8 6.8 7.4
6 6.0 8.3 7.8 5.7 9.2 7.4
7 6.6 14.6 9.1 13.6 10.7 10.9
8 10.6 8.1 10.5 6.9 6.8 8.6
9 3.9 7.9 9.8 8,3 10.7 8.1
10 7.4 7.7 7.4 7.1 8.9 7,7






I I 3.5 to 5.4 per 100,000
llll 5.5 to 7.4 per 100,000
7.5 per 100,000 and greater
Fig. 14.— Geographic distribution of 
leukemia incidence in Oklahoma, 1961-1965.
TABLE 6
LEUKEMIA INCIDENCE RATES FOR THE 
TEN H ILL-BURTON REGIONS IN 
OKLAHOMA, 1961-1965^
Region 1961 1962 1963 1964 1965 AverageAnnual
1 4.8 4.8 5.3 5.5 6.6 5.4
2 7.1 5.7 6.3 9.6 3.4 6,4
3 5.3 3.0 5.8 7.1 10.5 6.3
4 4.1 6.2 7.1 11.0 7.0 7.1
5 2.6 1.7 6.0 6.0 3.4 3.9
6 6.0 3.7 4.5 4.5 4.8 4.7
7 6.6 4.5 8.2 4.9 8.9 6.6
8 9.9 6.6 9.8 4.8 7.5 7.7
9 8.4 5.9 4.9 12.2 5.3 7.3
10 9.0 7.0 8.8 5.6 7.7 7.6
^Cases per 100,000 population.
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mortality than the others although Regions 3, 4, and 7 
show moderate mortality rate elevations (average annual 
rates greater than 10 per 100,000). Region 3 exhibited 
rates above state and national averages for all five 
years. Exceptionally high rates in 1964 and 1965 are 
responsible for this elevation. Region 4 experienced 
elevated mortality rates in 1962, 1963, and 1965. Though 
1961 and 1964 rates were below average, the other three 
years were sufficiently elevated to produce a five-year 
average rate of greater than 10 deaths per 100,000.
Region 7 experienced high mortality from leukemia in 1962 
and again in 1964 of sufficient magnitude to result in a 
five-year average rate of greater than 10 per 100,000.
The 1965 mortality rate in Hill-Burton Region 1 was sig­
nificantly greater than the average annual rate for 
Region 1^ (significant at 0.10). No other differences 
were significant. Leukemia incidence for the 10 Hill- 
Burton Regions is less remarkable, and little correlation 
can be observed between their mortality and morbidity 
experience. However, a difference significant at the
^Significant differences were determined by 
constructing confidence limits for each year around the 
five-year average annual rate. The Standard Error was 
calculated by the formula:
S. E. = R
"i
where R equals the five-year average annual rate and n^
equals the number of leukemia deaths for the year under 
consideration.
46
0.05 level was observed between tbe 1965 incidence rate in 
Region 3 and the average annual rate for that Region.& A 
difference significant at the 0.10 level was observed 
between the 1964 incidence rate in Region 4 and the aver­
age annual rate for that Region.& A difference significant 
to the 0.05 level was observed between the 1964 incidence 
rate in Region 9 and the average annual rate for that 
Region.&
Age-adjusted rates were also computed for each 
county in the state, for each year, and for the five-year 
study period. Table 7 shows the incidence and mortality 
characteristics of the three counties which met or exceeded 
criteria established in chapter ii defining "cluster coun­
ties." Twenty-one cases of leukemia were diagnosed in Kay 
County during this time. Table 7 shows that 8 (31.8%) of 
these cases were diagnosed in 1962, resulting in an inci­
dence rate of 15.7 cases per 100,000 population. Four of 
these 8 cases were acute leukemias in children and adoles­
cents, Nineteen hundred sixty-one was also a high year with 
six cases and a rate of 11.7 per 100,000. The remaining
^Significant differences were determined by 
constructing confidence limits for each year around the 
five-year average annual rate. The Standard Error was 
calculated by the formula: --------
S.E. =
\ "i
where R equals the five-year average annual rate and n^
equals the number of leukemia deaths for the year under 
consideration.
TABLE 7
OKLAHOMA COUNTIES WITH SUSPECTED 
LEUKEMIA CLUSTERING,1961-1965
COUNTIES 1961 1962 1963 1964 1965 5 YEAR
KAY COUNTY
Deaths 1 6 7 4 5 23&
Rate 1.9 11.8 13.6 7.8 9.6 8.9b
New Cases 6 8 3 2 2 21
Rate 11. 7 15.7 5.8 3,9 3.8 8.2
STEPHENS CO.
Deaths 4 8 8 2 6 28
Rate 10.5 21.0 20.9 5.2 15.6 14.6
New Cases 3 4 4 2 3 16
Rate 7.8 10.5 10.9 5.2 7.8 8.4
OTTAWA COUNTY
Deaths 1 6 3 4 7 21
Rate 3.5 20.8 10.2 13.5 23.3 14,3
New Cases 0 6 2 8 1 17
Rate 0.0 20.8 6.8 27.0 3.3 11,60
&Total cases or deaths.
^Five-year average rate per 100,000.
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three years were low. In 1963, the year after the 1962 
incidence peak, a mortality excess appeared in Kay County. 
For the total period 1961-1965, 8 of the new cases 
occurred in persons less than 25 years of age, and 13 were 
25 years and older. Of the 21 total new cases in the 
county, 10 were males and 11 were females. Twenty occurred 
in whites and only 1 (an Indian child) in non-whites. Of 
21 cases, 10 were acute leukemia, 10 were chronic lympho­
cytic leukemia, and 1 was chronic myelocytic leukemia.
The preponderance of older cases were females and the 
younger cases were mostly males.
The estimated 1965 population of Kay County is 
51,108. Fourteen of the 21 new cases diagnosed from 1961 
to 1965 resided in the county seat, Ponca City, a commu­
nity of 24,411 (1965 estimate). Interestingly, 13 of 
these 14 new cases in Ponca City resided in the western 
half of the city as shown in Figure 15. A home address 
was not available for one case. This concentration of 
cases in one part of the city is not the result of non- 
uniform distribution of residential areas throughout the 
city. The aggregation of cases does lie immediately adja­
cent to refining facilities of two large petroleum 
companies located at the western and southwestern edges of 
the residential area of the city. Almost as striking as 
the aggregation of cases on the west side of the city is 




Fig. 15.— Places of residence of




the 14 cases diagnosed in Ponca City, 9 were acute leuke­
mias, 4 were chronic lymphocytic leukemias, and 1 was a 
case of chronic myelocytic leukemia. Seven of the 14 were 
under 25 years of age at diagnosis, and only 4 were over 
65. Six of the 14 were male and 8 were female. The 7 
cases outside of Ponca City showed no tendency to aggre­
gate. Kay County was recognized as a "cluster area" and 
further studies will be discussed later. A complete 
description of Kay County is contained in Appendix D.
Stephens County in Hill-Burton Region 6 in south- 
central Oklahoma experienced elevated leukemia mortality 
in 1962, 1963, and 1965 (see Table 7). Twenty-eight 
leukemia deaths were reported from 1961 to 1965. Of the 
28 deaths, 14 were male and 14 were female. Only 3 were 
under 25 years of age, and 11 were over 75. There were 
no non-white leukemia deaths recorded during this period. 
Sixteen new cases were diagnosed from 1961 to 1965. Of 
the 16, 11 were male and 5 were female. Ten of the 16 
were acute leukemias, 2 were chronic lymphatic, 2 were 
chronic myelocytic, and 2 were not specified. Of the 16 
new cases, 5 were in persons under 25 years of age, and 
only 1 was over 75. Three cases of acute leukemia were 
diagnosed in white males in age group 65-74. There were 
no new cases reported in non-whites during the study 
period. Stephens County population is 38,281 (1965 esti­
mate) . Ten of the 16 new cases diagnosed resided in
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Duncan, the county seat and a community with a 1965 popu­
lation estimate of 20,009. These cases tended to reside 
in the east and northeast part of the city. Figure 16 
shows the locations of the residences of 9 of these cases. 
The tenth case gave only a nursing home address and is not 
represented. Two additional cases resided in the adjacent 
rural area just northeast of Duncan. The other 4 cases in 
the county showed no apparent tendency to cluster. Four 
of the 10 newly diagnosed cases in Duncan were in chil­
dren, and 6 were in adults. Stephens County was included 
as a cluster area, and further studies will be discussed 
later.
Ottawa County in extreme northeast Oklahoma expe­
rienced 21 leukemia deaths from 1961 to 1965 (see Table 7). 
Six deaths produced a mortality rate of 20.8 per 100,000 
population. Four deaths in 1964 and 7 in 1965 produced 
rates of 13.5 and 23.3 per 100,000 respectively. Twelve 
of the 21 deaths were in white males, and 5 of these were 
acute leukemias with onset prior to age 25. Ten of the 
21 occurred in persons 75 years of age and older. Four of 
these 10 were white males and 6 were white females. There 
were no reported leukemia deaths in non-whites, nor were 
there any deaths reported in persons under the age of 
5 years.
During the 1961-1965 time period 17 new cases of 
leukemia occurred in Ottawa County. Six of these were
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Fig. 16.— Places of residence of




diagnosed in 1962 yielding a rate of 20.8 per 100,000, 
and 8 cases were diagnosed in 1964 yielding a rate of 
27 cases per 100,000. There were no new cases diagnosed 
in 1961 and only 1 case in 1965. The average annual rate 
was 11.6 per 100,000. Of the 17 new cases, 9 were acute 
leukemias. Six of the acute cases occurred in persons 
under 35 years of age and 3 occurred in persons between 
55 and 74 years of age. There were 8 new cases of chronic 
leukemia, 4 chronic lymphocytic and 4 myelocytic. Six of 
these occurred in persons over the age of 75. There was 
1 non-white case, a 14 year-old Indian male.
Five of the 17 new cases diagnosed in Ottawa 
County have relatives or acquaintances with confirmed 
hematologic disturbances arising since the onset of leuke­
mia in each index case. The severity of these cases 
ranges from anemia to suspect leukemia. They will be dis­
cussed later.
Ottawa County has an estimated 1965 population of 
28,635. Miami, the county seat, has a population of 
12,869 (1965 estimate). Seven of the 17 new cases diag­
nosed in Ottawa County occurred in residents of Miami.
In Figure 17 the places of residence of these cases are 
seen. They are relatively uniformly distributed across 
the city. The 10 cases outside Miami are randomly dis­
tributed across the county. Ottawa County was considered 
a "cluster area" since the five year average mortality
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was greater than twice the U.S. average mortality for the 
same period. Further studies will be discussed in the 
next section. A complete description of Ottawa County is 
contained in Appendix D.
Kay, Stephens, and Ottawa Counties in Oklahoma 
have been described as experiencing "excessive" leukemia 
incidence and/or mortality from 1961 to 1965. As outlined 
in chapter ii, leukemia cases from these counties have 
been pooled and each matched by age, race, and sex with a 
non-leukemic control residing in the same neighborhood as 
the case. Control counties were also selected for each of 
the cluster counties, and control subjects selected for 
leukemia cases in the control counties to allow for com­
parisons between cases and their controls within cluster 
and control counties, and for comparison of cases and con­
trols between cluster and control counties. Complete 
descriptions of these three control counties are contained 
in Appendix D.
Figure 18 shows the locations of cluster and 
control counties. Thirty-nine of the 54 (72.2%) leukemia 
cases in the pooled cluster counties were interviewed, as 
were their 39 controls. Twenty-four of the 30 (80.0%) 
leukemia cases from the pooled control counties and their 
24 controls were also interviewed. Table 8 shows a com­
parison of these four groups by sex, race, age, and type 
of leukemia. Within the cluster counties, the sex and
C lu s te r  Area
C o n tro l Area
Fig. 18.--Location of cluster and 
control areas in Oklahoma, 1961-1965.
TABLE 8
CHARACTERISTICS OF LEUKEMIA CASES AND CONTROLS 
IN CLUSTER AND CONTROL COUNTIES 
IN OKLAHOMA, 1961-1965
CLUSTER COUNTIES CONTROL COUNTIES
Cases Controls Cases Controls
No % No. % N o . % No. 7o
Total 39 100 39 100 24 100 24 100
Male 25 64.1 25 64.1 18 75 18 75
Female 14 35.9 14 35.9 6 25 6 25
White 37 94.9 37 94.9 24 100 24 100
Non­
white 2 5.1 2 5.1
Acute 28 71.8 8 33.3 . . . . .
Chronic
Lympho­
cytic 8 20.5 9 37.5
Chronic
Myelo­
cytic 2 5.1 6 25.0




I 39 .7 years 37.2 years 62. 3 years 64.7 years
Sex
ratiob 1: 1.77 1:1.77 1:3
1
1:3
^Variability due to control selection from ten- 
year age interval.
bRatio of females to males.
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race of cases and controls are of course identical, and 
mean ages are very close since these groups have been 
matched. The same comparisons, of course, hold for the 
control counties because of the matching. Between the 
cluster and control counties however, some interesting 
differences are observed. A striking difference is noted 
in the mean age of the two groups. In agreement with 
this mean age difference is an equally striking disparity 
in the observed proportions of acute leukemia between the 
two groups. Thirdly, a considerable difference exists in 
the sex ratios although the numbers are small.
Table 9 shows comparisons of the four groups 
interviewed in relation to the factors at the left column 
of the table. Leukemia cases in cluster counties reported 
histories of major surgery significantly^ more often than 
their controls in the cluster counties (significant at 
0.10 level). Major surgery was defined as any surgery 
requiring general anesthesia. Cases in cluster counties 
reported histories of radiation exposure more often than 
their cluster county controls (radiation exposure was 
defined as ever having been treated with radiation).
Cases in cluster counties reported family histories of 
fetal wastage more often than their cluster county con­
trols (history of fetal wastage was defined as two or more
^Significance was determined by the Fisher Exact
Probability Test.
TABLE 9
LEUKEMIA CASE AND CONTROL PROFILE SUMMARIES :FOR CLUSTER
AND CONTROL COUNTIES IN OKLAHOMA, 1961 -1965
CLUSTER COUNTIES CONTROL COUNTIES
HISTORY Cases Controls Cases Controls
# % # % % # %
Major surgery 10 25.6 3 7.7 5 20.8 2 8.3
Major illness 15 38.5 8 23.1 11 45.8 7 29.2
Toxin exposure 12 30.8 5 15.4 11 45.8 3 12.5
Immunization reactions 2 5.1 0 0.0 1 4.2 0 0.0
Recurrent infection 15 38.5 6 17.9 11 45.8 7 29.2
Allergies 7 17.9 8 23.1 10 41.7 7 29.2
Radiation exposure 7 17.9 3 7.7 5 20.8 3 12.5
Birth defects 2 5,1 1 2.6 0 0.0 0 0.0
Familial cancer 13 33.3 9 25.6 10 41.7 7 29.2
Second malignancy 3 7.7 1 2.6 8 33.3 1 4.2
Fetal wastage 6 15.4 2 5.1 6 25.0 2 8.3
Family birth defects 3 7.7 0 0.0 0 0.0 0 0.0
Household pets 15 38.5 17 43.6 12 50.0 13 54.2
111 pet exposure 7 17.9 2 5.1 3 12.5 1 4.2
Livestock exposure 9 23.1 13 33.3 5 20.8 6 25.0
LnVD
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stillbirths or abortions among first degree relatives). 
Cases in cluster counties reported more exposure to ill 
pets than did their cluster county controls. Cases in 
control counties reported a greater prevalence of malig­
nant disease in addition to their leukemia. These 
differences were not significant.
No significant differences were observed between 
leukemia cases in control counties and their controls. 
However, the cases did report considerably more exposure 
to toxic chemicals, more histories of malignancies other 
than leukemia, and more family histories of fetal wastage, 
than their controls. Comparison of controls from cluster 
counties with controls from control counties reveals a 
very consistent pattern with respect to all factors.
Because of the difference observed in the propor­
tion of acute leukemia cases between cluster counties and 
control counties, further examination of leukemia experi­
ence in cluster and control counties was made. Table 10 
gives a breakdown of leukemia cases, within cluster and 
control counties, by acute and chronic types, and includes 
mean ages, numbers of males and females, and whites and 
non-whites for each type of leukemia. The mean ages of 
acute leukemias in cluster and control counties are 
clearly different. The difference between the mean ages 
of chronic leukemias is negligible.
TABLE 10
CHARACTERISTICS OF LEUKEMIA CASES AND CONTROLS 
IN CLUSTER AND CONTROL COUNTIES
IN OKLAHOMA, 1961- 1965
MEAN




Acute Leukemia 33.8 yrs. 18 10 27 1
Chronic Leukemia 64.1 yrs. 7 4 10 1
Control Counties
Acute Leukemia 54.8 yrs. 7 1 8 0
Chronic Leukemia^ 67.1 yrs. 11 5 16 0
& Includes one case of "unspecified" leukemia.
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In Table 11 case profile summaries of acute and 
chronic leukemias in cluster and control counties are 
examined. It is observed that acute leukemias in the 
cluster counties reported significantly^ more histories 
of persistent infections than did chronic leukemias in 
cluster counties (significant at the 0.0001 level).
Table 11 shows that histories of major surgery, persis­
tent infections, fetal wastage, exposure to ill pets, and 
family histories of birth defects, were more often 
reported by acute leukemias in cluster counties than by 
acute leukemias in control counties though the numbers 
are too small for meaningful testing.
^Significance was determined by the Fisher Exact
Probability Test.
TABLE 11
LEUKEMIA CASE PROFILE SUMMARIES FOR CLUSTER AND 















Major surgery 9 32.2 1 10.0 3 38.6 2 12.5
Major illness 13 46.5 2 20.0 5 62.5 6 37.5
Toxin exposure 10 35.7 2 20.0 5 62.5 6 37.5
Immunization reactions 2 7.2 0 00.0 1 12.5 0 00.0
Recurrent infection 15 53.5 0 00.0 4 50.0 7 43.8
Allergies 6 21.4 1 10.0 3 38.6 7 43.8
Radiation exposure 6 21.4 1 10.0 2 25.0 3 18.5
Birth defects 2 7.2 0 00.0 0 00.0 0 00.0
Familial cancer 10 35.7 3 30.0 4 50.0 6 37.5
Second malignancy 2 7.2 1 10.0 2 25.0 6 37.5
Fetal wastage 6 21.4 0 00.0 3 38.6 3 18.5
Family birth defects 3 10.8 0 00.0 0 00.0 0 00.0
Household pets 13 46.5 2 20.0 5 62.5 7 43.8
111 pet exposure 7 25.0 0 00.0 1 12,5 2 12.5
Livestock exposure 6 21.4 3 30.0 3 38.6 2 12.5
cy>U)




Epidemiologic studies of leukemia are of great 
importance to many types of investigation concerning 
leukemia, in that they provide the firm descriptive base 
from which subsequent research of several kinds can grow.
The first logical step in the study of any disease 
involves defining and characterizing the disease process. 
This depends in part upon another step, i.e., describing 
the manner in which the disease process affects the human 
population. A descriptive epidemiologic study provides 
this essential information. It can also expose unexpected 
or unique aspects of the disease which serve as "clues" 
for further study. Application of epidemiologic methods 
in "controlled" studies can then yield more knowledge 
about the disease, allowing formulation of hypotheses 
regarding possible etiologic determinants. These broad- 
based descriptive studies, though carefully controlled, 
may produce information which may lend itself to several 
different interpretations. It is necessary to perform 
in-depth analytic studies, often dependent upon
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sophisticated laboratory procedures, to determine the 
validity of the several possible interpretations.
Leukemia is relatively rare; only about seven 
cases per 100,000 population occur each year in the 
United States (1). As a result, epidemiologic studies 
are usually retrospective in nature. The cost of pro­
spective studies of the size to produce a sufficient 
number of cases would be prohibitive. Only in very 
high risk populations, such as atomic bomb survivors 
in Japan (14, 19) and Mongoloids (92, 94, 130) have pro­
spective techniques been extensively employed. With 
retrospective studies, large population bases must be 
effectively dealt with to reduce error and produce reli­
able incidence rates. As a result, most studies have 
utilized readily available and relatively complete mor­
tality registers. Studies which utilize and compare 
different systems of data acquisition, e.g,, mortality 
versus incidence data, show great promise in solving 
problems posed by inadequate, out-dated sources of infor­
mation, and will make more refined, more powerful 
epidemiologic methods available to the study of chronic 
disease. These methods will necessarily be expensive, 
but the more direct inferences made possible by better 
quality data will justify this expense.
Several sources of error are inherent in any 
study of this nature; their presence and effect must be
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realized and minimized by the institution of appropriate 
control measures whenever possible. Potential sources of 
error in this study have been noted by the author in the 
text of chapter ii. The most important of these are the 
failure of death registration data to accurately describe 
disease incidence in time and space, loss of cases due to 
dissimilar access to medical care services, under­
reporting, out-of-state referral, non-response or inabil­
ity to locate subject for interview, difficulty in 
standardization of interview technique, the questionable 
ability of relatives to provide requested information, and 
the lack of comparability in interviews between the rela­
tives of leukemia cases and control subjects (relatives 
of cases were interviewed whereas control subjects were 
interviewed directly).
Greatly refined diagnostic methods have been 
largely responsible for the differentiation of the many 
types of leukemia now encountered in pathology and hema­
tology texts. The exact relationship of these disorders 
is not fully known, though it is generally accepted that 
similar pathogenic mechanisms are involved (1). The 
variability observed in leukemia cases appears very much 
dependent upon age, race, and sex. Many experts feel 
that the variability observed in clinical and hematologic 
manifestations result from host factors and environmental 
differences, but that the initial event in the development
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of the disease is similar, if not identical, in all cases 
(79, 84). Some workers feel that leukemia is a very gen­
eralized response to an entire spectrum of initiating 
factors (109, 110).
The findings of this study are largely compatible 
with similar work done by others (35, 36, 119). The sex, 
race, and age distribution of the cases have been within 
the ranges of normal variability. The geographic distri­
bution of the disease, including the cluster counties 
identified in the study were not unexpected. Where the 
disease has been thoroughly studied, these aggregations 
have been found. It is felt by several authors (44, 64, 
66) that these phenomena represent unusual events, pecu­
liar to the time and place in which they occur, that they 
indicate abnormal amounts of etiologic factors, and as 
stated in chapter i, provide an unusual opportunity to 
identify these factors. The controlled studies within 
leukemia cluster sites also produced results generally in 
agreement with those of other investigators. Such factors 
as histories of unusual exposure to radiation, increased 
familial tendencies, congenital defects and fetal wastage, 
and histories of lymphatic tissue surgery (tonsillectomies 
and appendectomies) have been well documented (1, 19, 27, 
29, 81). They provide starting points for more specific 
and sensitive studies.
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In addition, unusual occurrences, seldom reported 
in studies of leukemia, have been observed. An unusual 
familial incidence of leukemia was noted in one community 
studied (136). The rare occurrence of monocytic leukemia 
in a man and his wife was noted. One additional finding 
observed in the study involved several cases of leukemia 
and other malignancies associated with a single wood-frame 
residence in southwestern Oklahoma. Miami, in Ottawa 
County, a cluster community, experienced a truly unusual 
incidence and mortality during the past several years, 
wherein several of the cases studied have surviving rela­
tives with a broad spectrum of hematologic disorders, 
ranging from chronic, unexplained anemia to chronic rela­
tive lymphocytoses. These phenomena constitute complete 
studies in themselves and merit further study and discus­
sion. They are excellent examples of the manner in which 
descriptive epidemiology can identify specific problems 
for further, more detailed examination.
Since the clustering phenomenon was first 
described (66) workers have pondered concerning the dif­
ferences in conditions that might exist between these 
cluster communities and other communities, in addition to 
their leukemia experience. This study has indicated that 
such differences may in fact exist, namely that cluster 
areas experience not only a greater number of leukemias 
per unit population, but that an unusual proportion of
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these cases are acute leukemias, occurring in younger 
persons. One interpretation of this finding is that the 
leukemia excess observed in cluster communities may be 
due almost entirely to acute leukemia, and thus suggests 
a high level of one or more etiologic determinants spe­
cific for the acute form of the disease. It may also be 
hypothesized that a high level of a non-specific leuke- 
mogen would tend to shift newly occurring cases toward the 
acute end of the severity spectrum, while at the same time 
producing an excess of acute or chronic leukemia that 
would otherwise not have occurred.
A number of investigators (95, 116, 121) have 
discussed the possible role of viruses in the etiology of 
leukemia. Others (3, 70) have noted the greater severity 
of many viral infections when initial exposure to the 
virus is postponed until later in life. Poliomyelitis is 
one example of a viral disease that is more severe with 
increasing age. Prior to the advent of polio vaccine the 
disease tended to occur in the paralytic form more often 
in upper-middle class communities where exposure to the 
polio virus may be delayed by modern sanitation measures 
until an older age. Acute leukemia is also more common 
among the upper-middle class (27), and a viral agent has 
long been suspect though not yet proven. If infection 
with a "leukemia virus" is delayed past the age when 
infection "generally" occurs, and an unusually severe
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infection results, it is interesting to speculate as to 
what would be expected to occur in populations where expo­
sure to the "virus" has been delayed by modern sanitation 
or other factors, resulting in perhaps large numbers of 
susceptible persons for later, potentially more severe, 
infection. Under these circumstances, clusters or 
"epidemics" of acute leukemia might occur when the virus 
is introduced. Variation in the latent period of the dis­
ease, unknown factors relating to host resistance and 
environment, and even the high mobility of modern society 
might make such outbreaks rarely observed phenomena.
A relatively large number of "cluster" areas have 
been described in the literature (29, 36, 45, 54, 64, 65, 
66, 80, 85, 139). Though techniques for statistical eval­
uation of these phenomena are yet in their infancy, and 
though seroepidemiology has not contributed greatly to 
their understanding, sophistication of these and other 
tools can be expected to yield more sensitive appraisals 
of such time-space aggregations, and thus contribute con­
siderably to the understanding of the disease. Greater 
. insight into factors now felt to be important in the 
development of leukemia may make possible the selection 
of high-risk cohorts to be followed in longitudinal 
studies. Much information regarding essential sequences 
of events in the development of chronic and acute neo­
plastic disorders await such study methods.
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In 1968 Assal (144) described the geographic and 
secular clustering of malignant disease mortality in 
Oklahoma, 1956-1965. He examined malignancies involving 
thirty-four sites. Among his observations were that leu­
kemia is one of three malignancies accounting for 
increased mortality from cancer since 1930, and that 
leukemia mortality rates show considerable variability 
from county to county.
Mortality rates for leukemia in the United States 
averaged 7.1 per 100,000 population during the 1961-1965 
period (138). No apparent yearly trend is observable in 
these rates although U.S. leukemia mortality rates have 
increased steadily since the early 1920’s (52). In 
chapter iii it was mentioned that leukemia mortality 
rates in Oklahoma exceeded those of the U.S., and that 
was a pronounced increase in Oklahoma rates from 1961- 
1965. A review of Figure 1 shows this. The significance 
of the U.S.-Oklahoma difference is questionable since it 
could have resulted from the innate random variability in 
mortality patterns. The increase in Oklahoma mortality 
rates from 1961 to 1965 may also be due to random vari­
ability in mortality, although the further separation of 
the United States and Oklahoma curves in 1964 and 1965 may 
suggest the presence of additional factors.
Acute leukemia is the most common form of leukemia 
(44, 52). Figures 2 and 8 indicate that acute leukemia
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was the most predominant form encountered in this study,
A comparison of these two figures also reveals that each 
incidence peak is followed the next year by a mortality 
peak. The short average survival time of acute leukemia 
produces this pattern. Acute leukemia tends to be a dis­
ease of the extremes of life. Figures 5 and 11 show a 
definite bimodality in mortality and incidence. This 
distribution is classical for acute leukemia (44). It has 
been interpreted as meaning that acute leukemia in child­
hood may not be the same disease as that seen in adults. 
Others have suggested that the same initiating factors 
may be acting in both groups, but that environmental or 
certain host factors may be responsible for the differ­
ences in the age of expression of the disease (27). The 
age distribution of leukemia cases has also been corre­
lated with changes in immunological competence that 
apparently occur with age (102). Specifically, it is 
hypothesized that immunological competence, or the abil­
ity of the body to recognize foreign or defective tissues 
or cells, decreases with age, allowing aberrant cell 
growths that were retarded before, to grow, i.e., the 
"forbidden clone" hyphothesis (116). Some feel that a 
similar alteration (inherent or induced) in immunological 
competence might occur in childhood, thereby initiating 
or predisposing to the leukemic process (17). Though the 
data presented are consistent with many "theories"
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regarding the etiology of the disease, recent work in 
tumor immunology makes this an increasingly attractive 
one (113, 118).
A review of Figures 5 and 11 reveals an interest­
ing difference in mortality and incidence from acute 
leukemia in the under five age group. At most points 
these two curves are very similar; however, in the under 
five age group mortality is considerably less than inci­
dence. This could be interpreted in several ways. The 
possibilities range from under-reporting of acute leuke­
mia deaths in this age group to greater survival 
experience in this age group.
Chronic leukemia shows unexpected variability 
within the mortality data and also within the incidence 
data. As mentioned in chapter iii, chronic lymphocytic 
leukemia and chronic myelocytic leukemia are usually 
observed in a rather constant ratio (119). Figure 2 
shows anything but a constant relationship between these 
two types of leukemia. A similar pattern is seen in the 
incidence data in Figure 8. A poor correlation between 
incidence and mortality trends is not surprising con­
sidering the average time of survival in chronic 
leukemias, which is usually measured in years rather than 
in months as with acute leukemia.
The age distribution of cases included in the mor­
tality and incidence segments of this study are consistent
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with observed U.S. figures (44). Leukemia risk is great 
in the young, and decreases with increasing age until the 
forties where risk begins increasing with age. Leukemia 
risk is greatest in the eldest. This finding has been 
interpreted as being consistent with the "cumulative" 
radiation leukemogenesis hypothesis (14, 19, 28).
Fraumeni (47) has observed in U.S. mortality statistics 
that a mortality peak has recently developed in three- 
and four-year-old whites, but not in non-whites, suggest­
ing a possible delay in the exposure of non-whites to 
some environmental leukemogen. The same peak can be 
observed in Oklahoma mortality data, although involving 
numbers insufficient to warrant further comment.
In several instances in chapter iii it was 
observed that mortality and incidence curves often had a 
tendency to decrease in the 75 and older age group 
whereas the trend had been steep increases with increas­
ing age prior to that point. This could result from 
increasing mortality from other causes, or might be the 
effect of under-reporting that results when older persons 
with long-standing leukemia die from other causes.
It has been well documented that definite sex and 
race differences exist with regard to leukemia (1, 44, 46, 
69). Figures 6 and 12 in chapter iii show that both leu­
kemia mortality and incidence show great sex and race 
differences. The white male is at greatest risk of
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leukemia throughout life (44). White females, non-white 
males, and non-white females follow in that order. These 
differences have led some to believe that non-whites, 
particularly females, may possess some protective mecha­
nism (46). Conversely it has been suggested that white 
males may encounter greater exposure to environmental 
factors of leukemogenic potential than either white 
females or non-white males or females, and at the same 
time have access to superior diagnostic facilities than 
non-whites in general (131). Differences in non-white 
males and non-white females may also be due to similar 
environmental differences that white males and females 
experience. The difference in whites and non-whites has 
been interpreted as a delayed exposure of the non-white 
population to some environmental leukemogen (119). Super­
vening death by race-specific causes and differences in 
accessibility to diagnostic facilities might tend to 
affect leukemia incidence in the same manner.
Figure 7 in chapter iii shows the comparison of 
leukemia incidence and mortality. Because of the compre­
hensive registration of leukemia deaths, mortality is a 
very accurate estimate of the number of cases occurring. 
Incidence data are desirable however since they are rela­
tively free of the distortion resulting from the variable 
length of case survivals. Incidence measured by study of 
hospital records is 75.5% of registered mortality for the
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same period. Comparison of Figures 5 and 7 shows that 
mortality and incidence from acute leukemia are almost 
identical, chronic myelocytic is also very close, but 
chronic lymphocytic leukemia is underestimated. Though 
the study of medical records does involve some loss of 
case coverage, takes more time and is more costly, the 
ability of this method to pinpoint spatial and temporal 
aggregation clearly justifies its use on a selective 
basis. The accuracy and timeliness of the data so obtained 
is required for more refined studies of time-space cluster­
ing.
Figure 7 shows that leukemia incidence was sharply 
decreased in 1962. The reasons for this decrease are not 
clear. Figure 8 shows substantial decreases occurring in 
chronic myelocytic leukemia in 1962, along with lesser 
decreases in acute leukemia, and other kinds of leukemia. 
Figure 2, however, shows increases in 1962 over 1961 in 
acute leukemia and in chronic lymphocytic and chronic 
myelocytic leukemia mortality. Most of the decrease is 
clearly in chronic myelocytic leukemia; however, there is 
no explanation for this.
Heath and Hasterlik (66) were among the first to 
document that leukemia cases cluster in time and space.
They suggested that such clustering might indicate unusual 
distribution of some etiologic factor, providing a unique 
opportunity to identify that factor. The present study
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has compared "cluster areas" with non-cluster areas for 
differences other than their leukemia experience, for 
differences in leukemia cases between them, and for dif­
ferences between leukemia cases and matched controls 
within the cluster areas.
Three counties in Oklahoma were defined as 
"cluster counties" by arbitrarily established criteria 
(chapter ii). These three counties (Kay, Stephens, and 
Ottawa) experienced 54 new cases of leukemia from 1961- 
1965. Thirty-nine of these 54 (72.2%) were interviewed 
and case profiles were constructed for purposes of the 
comparison presented in chapter iii. Interviews could 
not be obtained in 15 cases. Each of the 39 cases was 
matched by age, race, and sex, with a control residing in 
the same community.
Three "control" counties were also selected, each 
one matching in size, population, location, and general 
socioeconomic and ecological characteristics, one of the 
three cluster counties. Rogers, Carter, and Washington 
Counties were chosen. These control counties experienced 
30 cases of leukemia from 1961 to 1965. Interviews were 
obtained in 24 of the 30 (80.0%) and case profiles were 
constructed.
Kay County experienced an unusual aggregation of 
cases in the county seat, Ponca City. As observed in 
chapter iii this city is bordered on the south and
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southwest by extensive petroleum refining facilities of 
two oil companies. The effluent of these facilities is 
carried into the neighboring residential areas in warm 
weather when winds are southerly, and away from the city 
when winds are northerly. The exact relationship of this 
effluent to the unusual leukemia incidence in the adjacent 
residential area is unknown but interesting. It is well 
documented that certain aromatic hydrocarbons are associ­
ated with the development of leukemia in man (32, 124,
128). It is interesting to speculate as to the exact 
relationship, if any, between the chronic exposure to the 
effluent in this community and the unique distribution of 
leukemia cases.
An additional observation of interest regarding 
the Stephens County cluster is the development of a case 
of lymphoma in a pet, a Siamese cat, in the home of one 
of the childhood cases, shortly after the death of the 
child. This cat gave birth to a litter of kittens shortly 
before death, all of which (except one) have since devel­
oped lymphomas and died. The one surviving animal is in 
the possession of the Oklahoma State University College 
of Veterinary Medicine, where the entire litter was taken 
after the death of the mother. Studies of these animals 
are still in progress but have not yielded relevant infor­
mation concerning the possible relationship of hematopoi­
etic disorders in man and animals.
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Ottawa County experienced an unusual leukemia 
incidence from 1961 to 1965. In addition to this, hema­
tologic disorders have been confirmed in close relatives 
(and one physician) of five of the deceased cases. These 
include two cases of unexplained, relatively severe 
anemias in first degree relatives, a single case of an 
unexplained relative and absolute lymphocytosis in the 
physician who treated several of the leukemia cases, one 
case of suspected leukemia in a first degree relative with 
prolonged household case exposure, and one case of an ado­
lescent girl with persistent lymph node enlargement and 
fever during the course and after the death of a sib.
None of these cases has developed leukemia as far as is 
known.
The comparison of cluster and control areas have 
shown some interesting differences. The mean age differ­
ence mentioned in chapter iii, along with the difference 
in the proportion of acute leukemias is an interesting 
observation. A difference also exists in the proportion 
of chronic myelocytic leukemia although the latter numbers 
are rather small.
The Profile summaries (Table 9) of cases and con­
trols in the respective cluster and control counties show 
a number of interesting differences. These differences, 
though, should be cautiously interpreted because of the 
small numbers involved. The difference in the number of
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cases and controls with histories of major surgery may 
indicate the tendency to infection that often precedes 
leukemia for months or years before the disease is diag­
nosed (Table 9). Most of the surgeries are appendectomies 
and tonsillectomies. These same findings have been inter­
preted by others as indicative that lymphoid tissues, e.g., 
tonsils and appendix, may play a role in defending the 
body against malignancies (113).
An interesting difference was observed between 
cases and controls in cluster areas regarding exposure to 
radiation. The association between ionizing radiation 
and acute and chronic myelocytic leukemia is well docu­
mented (14, 19, 24, 28, 51, 56, 60, 74, 78, 81, 95, 122, 
125, 137). Radiation exposure is not associated with 
chronic lymphocytic leukemia (56, 74). An examination of 
Table 11 shows that of the seven cases of leukemia in 
cluster counties reporting a history of radiation exposure, 
six are acute leukemias, lending greater significance to 
the differences observed between the cases and controls in 
this instance.
The difference in reported fetal wastage, between 
cluster cases and their controls, noted in Table 9 has 
been documented by others (51). The percentages given 
are based upon small numbers, however the same difference 
is observed between leukemia cases and their controls in 
control counties.
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Leukemia patients report exposure to ill house­
hold pets more often than controls (51). Table 9 supports 
this finding both in differences in cluster counties and 
in control counties.
In control counties exposure to toxic chemicals, 
a history of malignancy other than leukemia, and a history 
of fetal wastage are more common in cases than in con­
trols.
Malignancies other than leukemia were more often 
reported by leukemia cases in control counties than by 
leukemia cases in cluster counties. This may be related 
to the difference in mean age observed between the two 
groups, in that older persons would be expected to have 
second malignancies more frequently than younger persons 
since frequency of malignancies increases with age.
Because of the difference observed in the mean 
ages and the increased proportion of acute leukemia in 
cluster versus control counties, cases within cluster and 
control areas were examined with regard to type of leuke­
mia. Table 10 shows that most of the difference observed 
between mean ages in cluster county cases and control 
county cases was due to acute leukemia, as a striking dif­
ference is observed in mean age of acute leukemia cases 
in cluster counties and acute leukemia in control coun­
ties. As mentioned in chapter iii acute leukemias in 
cluster counties reported more major surgery, persistent
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infections, fetal wastage, and exposure to ill pets. It 
is interesting to note that no such differences are 
observed between acute and chronic leukemias in control 
counties.
The information contained in Tables 8 and 11 indi­
cates that leukemia cases occurring in clusters tend to 
differ from cases occurring outside clusters, in that a 
significantly greater proportion of cases in the former 
are acute. Furthermore, acute leukemia in cluster areas 
tends to occur in significantly younger persons than 
acute leukemia in non-cluster areas. This evidence may 
lend itself to several interpretations, one of which is 
that leukemia occurring in clusters tends to be basically 
"different" than leukemia occurring outside clusters, 
suggesting that environmental or other factors of etio­
logic consideration may also be different.
Although this study has revealed interesting dif­
ferences in cases from one area to another, it has been 
unable to identify any environmental factors which might 
be associated with these differences. If such differ­
ences do exist, they might be difficult to measure. 
Supposing a viral etiology in acute leukemia, the immu­
nity of the population to the infectious agent might vary 
greatly from place to place. Such information would have 
to come from a population survey of immune status. Per­
haps work with the EB virus will lead to such capability 
(38 40).
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Environmental factors of known leukemogenic 
potential, e.g., radiation, would be relatively easy to 
measure, but information concerning the levels of such 
factors in the past would generally not be available. 
Routine radiation surveillance is not presently of suf­
ficient scope to facilitate such study.
A comprehensive environmental appraisal of leuke­
mia cluster areas, and a comparison of these with non­
cluster areas, could shed additional light on the cluster 
phenomenon and perhaps provide important clues to the 
etiology of human leukemia.
CHAPTER V 
S U M M A R Y
A study was undertaken to determine mortality and 
incidence from leukemia in Oklahoma from 1961 through 
1965, to describe salient epidemiologic features of the 
disease, to determine whether or not spatial-temporal 
clustering of cases occurred, and then to compare the leu­
kemia experience of cluster and matched control areas.
Leukemia mortality data summarized from death 
registration certificates filed with the Oklahoma State 
Department of Health, for all leukemia deaths from 1961 
through 1965, were obtained. In addition, leukemia inci­
dence data were secured by examination of the hospital 
records of all persons hospitalized with leukemia in all 
fifty-two accredited hospitals in Oklahoma from 1961 to 
1965.
These two sources of information were analyzed by 
age, race, sex, type of leukemia, date of onset (or death) 
and place of residence at onset (or death). Mortality and 
incidence rates were computed for each county, for each 
multi-county Hill-Burton region, and for the state, for
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each year and for the five-year 1961-1965 period.
The age, race, and sex composition of the leukemia 
population was within expected ranges, with the disease 
demonstrating a characteristic bimodal age distribution 
with a peak in the very young and a second higher peak in 
the elderly. White males had the highest race-sex spe­
cific incidence and mortality rates. White females were 
second, non-white males third, and non-white females fourth,
The types of leukemia observed were essentially 
identical in the mortality and incidence data with the 
exception of an apparent underestimation of chronic lympho­
cytic leukemia incidence. Acute leukemia was the most 
common type observed in both mortality and incidence data. 
The proportion of acute leukemia decreased with age while 
chronic leukemia proportions (lymphocytic and myelocytic) 
increased.
The geographic distribution of leukemia incidence 
and mortality did not show significant differences in any 
of the Hill-Burton regions. The ten regions contributed 
almost equally to the net increase in Oklahoma leukemia 
mortality from 1961 through 1965. However, three Oklahoma 
counties experienced sufficient leukemia incidence and/or 
mortality to meet arbitrarily defined requirements for 
"leukemia cluster areas."
The three cluster counties were matched with three 
neighboring control counties of approximately equal size
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and population, and with essentially normal leukemia expe­
rience. Leukemia cases within cluster counties were pooled 
as were those in the control counties, to facilitate com­
parisons of the two groups of leukemia cases. In addition, 
age-, race-, and sex-matched control subjects were selected 
for all leukemia cases in cluster and control counties.
Descriptive profiles were constructed for all sub­
jects (cases and controls) consisting of information 
obtained in a personal interview with either the subject 
or a surviving relative. This information related to past 
medical history, family history, and exposure to known or 
suspected leukemogenic agents. The descriptive profiles 
of leukemia cases were then compared with those of their 
non-leukemic controls in cluster counties, and with those 
of leukemia cases in control counties.
These profile comparisons revealed some interesting 
differences. For example, a mean age of 39.7 years was 
observed in leukemia cases in cluster counties, whereas 
the mean age for cases in control counties was 62.3 years, 
reflecting a higher proportion of acute leukemia in youn­
ger persons that was observed in the cluster counties. 
Significantly more leukemia cases in cluster counties than 
their non-leukemic controls reported (1) histories of 
major surgery, (2) familial histories of fetal wastage, 
and (3) histories of exposure to ill household pets. A 
single significant difference was noted between cluster
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county leukemia cases and control county leukemia cases 
(excepting the mean age difference mentioned above), and 
this was the more frequently reported history of second 
malignancies in control county cases.
These findings are thought to indicate that basic 
differences in leukemias in cluster versus control coun­
ties may exist, and that these differences may be related 
to identifiable environmental or host factors which pre­
dispose to leukemia in man.
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APPENDIX A
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a-(SJ NCDC »
M ED ICA L R E C O R D . T h is  form co n ta in s  m ed ica l in form ation  th e  d i s c lo s u r e  
Of r e le a s e  of w h ich  i s  r e s tr ic te d  by S U .S .C . 5 5 2 , (b ) ( 6 ) :  45 C F R  P a r t  S .
LEUKEMIA - LYMPHOMA 
CASE RECORD
I P A T IE N T 'S  NAME Urtl, middlm. n.i3> l a s t
2  R ESID EN CE number ond ttnmt
( I d - 1 7 )  C ity (lt-20) C cunty
3 . (31) RACE
□  l W hite □  2
O ther, so ec ifv
Negro r~ l9  Not s ta ted
4. (32) SEX
1 11 Mole O  2 Fema le [ } 9 Not s ta ted
5 . (33-34) AGE AT
DIAGNOSIS
6 . DATE O F:
(35-38) R irth
mo. day ■ yr.
(39-A2) O n se t
mo. yr-
(43-46)  D iag n o sis
mo. do .
(47-50) D eath
(2I-30)  A ddrass C oord inates (NCDC U s .  O n lf)  
(11-741 ~ (25-17) (ia-30)
1 0 .  (5 9 ) LEUKEM IC 
C E L L  TYPE
USE fS3-54} o-ct f55-56J d24-<i
8 .  (57) G EN ERA L DIAGNOSIS 
r~1 1 Leukem ia 
Q  S Leukem ia & lymphoma 
Q  4 O ther,
sp ec ify ______________
r~l 2 Lymphoma
9 .  (5 9 )T Y PE OF LEUKEMIA 
n  1 A cute 
I 12 Chronic 
r~13 O ther,
sp ec ify ____________
I 14 Subocute 
I I 9 Not s ta ted
11. (50) T Y PE OF LYMPHOMA 
n  1 H odgkin 's 
I~ l2  Lym phosarcom a 
r~13 R eticulum  ce ll sarcoma 
f~~l4 O ther,
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O  5 M ultiple myeloma 
0 9  Not s ta ted
12. (61) UNUSUAL FEATURES (See in struc tions)
11 (77.50) LLCS
Nome o f p h y s ic ia n . 
A d d re s s___________
Name of h o s p i ta l . 
H o sp ita l * ______
D ote  of re p o r t . D eath  c e r tif ic a te
W O R K  S H E E T  -  D E V E L O P M E N T A L
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APPENDIX B
C L IN IC A L  RECO RD . T h is  foim  c o n ta in s  c l in ic a l  in fo rm atio n , th e  d i s c lo s u r e  or r e le a s e  
o f w h ich  IS re s tr ic te d  by 5 U .S .C . 552 . (b ) <6); 45 C F R  P a r t  5 ;  an d  42 C FR  P a r t  1.
LEUKEM IA -  LYMPHOMA 
C A SE INVESTIGATION
D A T E  O F  I N T E R V I E W
N A M E  O F  I N T E R V I E W E R
N A M E  O F  P A T I E N T R A C E S E X
A D D R E S S  A T  O N S E T D A T E  O F  B I R T H
D A T E  O F  O N S E T
P E R S O N  I N T E R V I E W E D  « N A M E  A N D  A D D R E S S ) R E L A T I O N S H I P D A T E  O F  D I A G N O S I S
P H O N E D A T E  O F  D E A T H
P R E S E N T  I L L N E S S
M E D IC A L  HISTORY
M A J O R  I L L N E S S E S .  O P E R A T I O N S T O X I N S .  D R U G S
P E R I N A T A L I M M U N I Z A T I O N S
P L A C E  O F  B I R T H R E S I D E N C E  A T  B I R T H
C O N G E N I T A L  D E F E C T S X - R A Y S I N F E C T I O N S
A L L E R G I E S
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FAMILY H IST O RY
N A M E S E X A G E B I R T H  D A T E D E A T H  D A T E H E A L T H
P A R E N T S
S I B S
S P O U S E
C H I L D R E N
F E T A L  D E A T H S O T H E R  ( E S P E C I A L L Y  C A N C E R .  L E U K E M I A ,  A N D  C O N G E N I T A L  D E F E C T S )
M U L T I P L E  B I R T H S
E N V IR O N M E N T A L  H IST O RY
H O U S E H O L D  A T  O N S E T
O C C U P A T I O N  O R  S C H O O L /  G R A D E
P A S T  R E S I D E N C E
H O U S E  A T  O N S E T
S O C I A L  C O N T A C T S
P A R E N T S '  B I R T H P L A C E :  
M O T H E R
C H U R C H  A T T E N D E D :
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APPENDIX C 
DESCRIPTION OF TEN HILL-BURTON REGIONS
Region I is located in northeastern Oklahoma and 
consists of nine counties--Craig, Creek, Delaware, Mayes, 
Okfuskee, Okmulgee, Ottawa, Rogers and Tulsa--covering 
6,216 square miles. The 1960 population of the region was 
533,673 with 73.2% residing in urban areas. The area pop­
ulation is 1 0 . 3 7 c  non-white which includes 5 5 , 5 0 0  negroes 
and 17,500 American Indians. The ratio of licensed physi­
cians to general population is 1:733; and of medical 
doctors to general population, the ratio is 1:1,321, 
Approximately 38% of the population is between 1 and 19 
years of age, 52% between 20 and 64, and 10% is 65 or 
older. Median years of school completed by person 25 and 
older is 11.0. Approximately 21% had less than eight 
years of schooling, and 9% had four or more years of 
college. There are 141,493 families in the region. The 
median annual family income is $5,251 with 35,160 families 
having annual incomes of less than $3,000 and 32,391 hav­
ing incomes in excess of $8,000 per year.
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Region II is located in east central Oklahoma and 
consists of six counties--Adair, Cherokee, McIntosh, 
Muskogee, Sequoyah and Wagoner--covering 4,173 square 
miles. The 1960 population was 138,785, with 60.9% resid­
ing in rural areas. The population is 20.4% non-white 
which includes 20,937 negroes and 11,389 American Indians. 
The ratio of licensed physicians to general population is 
1:971; and of medical doctors to general population, the 
ratio is 1:1,309. Approximately 40% of the population 
falls in ages 1 through 19, 47% in ages 20 through 64, 
and 13% is 65 and over. Median years of school completed 
by persons 25 and over is 8.7, 15.7% had less than 5 years 
of schooling, and 5.8% had four or more years of college. 
There are 35,515 families in the region. Median family 
income is $3,068 annually, with 17,461 families having 
incomes of less than $3,000 per year and 3,526 having 
annual incomes in excess of $8,000.
Region III is located in southeastern Oklahoma and 
consists of seven counties--Choctaw, Haskell, Latimer, 
LeFlore, McCurtain, Pittsburg, and Pushmataha--covering 
8,346 square miles. The 1960 population was 130,901 with 
73.3% residing in rural areas. The population is 13.6% 
non-white which includes 13,388 negroes and 6,270 American 
Indians. The ratio of licensed physicians to general pop­
ulation is 1:1,309; and of medical doctors to population, 
the ratio is 1:1,870. Approximately 38% of the population
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is between I and 19 years of age, 47.7% is 20 through 64, 
and 14.5% is 65 and over. The population 25 years of age 
and older has 8.4 median years of schooling, 18.9% has 
less than five years, and 4.4% has completed four or more 
years of college. The 33,972 families in the region have 
a median income of $2,601. Of these, 19,428 have annual 
incomes of less than $3,000, and 2,353 have annual incomes 
of $8,000 or more.
Region IV is located in the southeast-central part 
of Oklahoma and is comprised of six counties--Atoka, Coal, 
Hughes, Johnston, Pontotoc, and Seminole--covering 4,312 
square miles. The 1960 population was 95,714 with 57.8% 
residing in rural areas. The population is 12.1 non-white, 
which includes 7,045 negroes and 6,126 Indians. The ratio 
of licensed physicians to general population is 1:1,100; 
and of medical doctors, the ratio is 1:1,490. Approxi­
mately 37% of the population is between 1 and 19 years of 
age, 49.9% is between 20 and 64, and 13.9% is 65 and over, 
The population 25 years of age and over has 8.7 median 
years of schooling. Only 15.3% have less than 5 years of 
schooling; and 5.4% have four or more years of college.
The 25,940 families in the region have a median income of 
$3,060. Of these, 12,199 have annual incomes of less than 
$3,000, while 2,572 have $8,000 or more yearly income.
Region V is located in south-central Oklahoma and 
consists of six counties--Bryan, Carter, Garvin, Love,
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Marshall; and Murray--covering 3,810 square miles. The 
1960 population was 115,333, with approximately 52.3% 
residing in rural areas. The population is 6.9% non-white, 
which includes 7,281 negroes and 2,204 Indians. The ratio 
of licensed physicians to general population is 1:1,031; 
and of medical doctors to general population, the ratio 
is 1:1,480. Approximately 37% of the population falls in 
the 1 through 19 year group, 49.9% is 20 through 64, and 
13.3% is 65 and over. The median years of schooling for 
the population 25 years of age and older is 9.1. Only 
12.2% of the population have less than five years of 
schooling, and 5.6% have four or more years of college.
The 31,207 families in the region have a median annual 
income of $3,721. Of these, 12,906 have an annual income 
of less than $3,000, and 3,534 have incomes of more than 
$8,000 per year.
Region VI is located in southwestern Oklahoma and 
consists of seven counties--Caddo, Comanche, Cotton,
Harmon, Jefferson, Jackson and Stephens--covering 6,813 
square miles. The 1960 population was 223,879, with 
approximately 56% residing in urban communities. The pop­
ulation is 9.4% non-white which includes 21,500 negroes 
and 7,500 Indians. The ratio of licensed physicians to 
the general population is 1:1,420; and of medical doctors 
to the general population, the ratio is 1:1,829. Approxi­
mately 39% of the population falls in ages 1 through 19
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years, 52% in ages 20 through 64, and 9% is 65 and older. 
The median school years completed by persons 25 and over 
is 10.6 years. Only 7.6% have less than five years 
schooling, and 6.5% have four or more years of college.
The 56,075 families of this region have a median income of 
$4,221 annually, with 18,341 having annual incomes of less 
than $3,000, and 7,323 having incomes of $8,000 or more a 
year.
Region VII is located in the west-central part of 
Oklahoma and consists of Beckham, Blaine, Custer, Dewey, 
Greer, Kiowa, Roger Mills, and Washita Counties, covering 
7,587 square miles. The 1960 population was 103,863, with 
60.4% residing in rural communities. The population is 
2.7% non-white which is made up of 4,438 negroes and 
3,291 Indians. The ratio of licensed physicians to gen­
eral population is 1:1,125; and of medical doctors to 
population, the ratio is 1:1,533. Approximately 36% of 
the population is age 1 through 19, 51.1% is 20 through 
64, and 13.4% is 65 and over. Median school years of 
education for the population of 25 years of age and over 
is 9.8. Only 7.2% had less than five years schooling, and 
5.1% had four or more years of college. Of the 28,326 
families in the region, the median annual income is 
$3,789, with 10,686 families having an annual income of 
less than $3,000, and 3,731 having annual incomes of 
$8,000 or more.
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Region VIII is located in northwestern Oklahoma 
and consists of eleven counties--Alfalfa, Beaver, Cimar­
ron, Ellis, Garfield, Grant, Harper, Major, Texas, Woods, 
and Woodward--covering 14,251 square miles. The 1960 pop­
ulation was 140,238, with 58.2% residing in rural areas. 
The population is 1.5% non-white which consists of 2,300 
negroes and 400 American Indians. The ratio of licensed 
physicians to general population is 1:801; and of medical 
doctors, is 1:1,240. Approximately 36% of the population 
falls in ages 1 through 19, 51.8% is 20 through 64, and 
12.3% is 65 and over. The median school years completed 
by those 25 and over is 10.8, whereas 5.5% had less than 
5 years of schooling, and 6.9% had four or more years of 
college. The 37,776 families of the area earn a median 
annual income of $4,739, with 10,286 families having 
annual incomes of less than $3,000, and 6,596 families 
having incomes of $8,000 or more.
Region IX is located in north-central Oklahoma and 
consists of seven counties--Kay, Noble, Nowata, Osage, 
Pawnee, Payne, and Washington--covering 6,266 square 
miles. The 1960 population was 202,169, with 62.7% resid­
ing in urban communities. The population is 5.3% non­
white which consists of 5,000 negroes and 5,600 American 
Indians. The ratio of licensed physicians to general 
population is 1:899; and of medical doctors to general 
population, the ratio is 1:1,321. Approximately 38% of
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the population is ages 1 through 19, 51.7% is 20 through 
64, and 10.8% is 65 and older. The population of 25 years 
and over has completed a median of school years of 11.0, 
whereas 6.0% has less than five years of schooling, and 
10.3% has four or more years of college. The 53,549 fami­
lies in the region earn a median annual income of $5,072, 
with 12,914 families having annual incomes of less than 
$3,000, and 10,791 having annual incomes of $8,000 or more.
Region X is located in central Oklahoma and con­
sists of nine counties--Canadian, Cleveland, Grady, 
Kingfisher, Lincoln, McClain, Oklahoma, and Pottawatomie-- 
covering 7,203 square miles. The 1960 population was 
643,729, with 84% residing in urban areas. The population 
is 9.2% non-white which consists of 79,500 negroes and
13,000 American Indians. The ratio of licensed physicians 
to general population is 1:543; and of medical doctors to 
general population, the ratio is 1:673. Approximately 
38% of the population falls in ages 1 through 19, 52.8% 
is 20 through 64, and 9.2% is 65 and over. The median 
school years completed by persons 25 years of age and 
older is 11.4, whereas 6% have less than 5 years of 
schooling, and 9.6% have four or more years of college.
The 168,857 families in the region earn an annual median 
income of $5,285, with 38,443 families having annual 
incomes of less than $3,000, and 38,035 having annual 
incomes of $8,000 or more.
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I Northeast 6,216 533,673 10.3 26.8 1:733 11.0 $ 5251
II East-
Central 4,173 138,785 20.4 60.9 1:971 8.7 3068
III Southeast 8,346 130,901 13.6 73.3 1:1309 8.4 2601
IV Southeast-
Central 4,312 95,714 12.1 57.8 1:1100 8.7 3060
V South-
Central 3,810 115,333 6.9 52.3 1:1031 9.1 3721
VI Southwest 6,813 223,879 9.4 44.0 1:1420 10.6 4221
VII West-
Central 7,587 103,863 2.7 60.4 1:1125 9.8 3789
VIII Northwest 14,251 140,238 1.5 58.2 1:801 10.8 4739
IX North-
Central 6,266 202,169 5.3 37.3 1:899 11.0 5072
X Central 7,203 643,729 9.2 16.0 1:543 11.4 5285
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APPENDIX D
DESCRIPTIONS OF CLUSTER AND 
CONTROL COUNTIES
Kay County is located in northern Oklahoma approx­
imately 100 miles north of Oklahoma City. The county has 
an area of 944 square miles and had a 1960 population of 
51,042 (1965 estimate; 52,020), 48,588 of which were 
white, and 2,484 non-white. The median age of the white 
population was 34.6 years, and that of the non-white was 
21.9 years. The two major population centers of the 
county are Ponca City, with 24,000 residents, and Black- 
well with 9,580. Remaining population is distributed 
between several smaller communities and the rural areas 
of the county. The economy of the area is strongly 
dependent upon two large oil companies having refining 
facilities near Ponca City. Agriculture and small private 
business essentially comprise the remaining economy.
According to the Oklahoma Geological Survey, Kay 
County lies entirely within a major area of oil and gas 
production. The county is characterized by surface rock 
strata of the Quaternary and Lower Permian, the latter
114
' 115
lying principally along streams. The topography is 
described as essentially Central Red-bed Plains in the 
western two-thirds of the county and Northern Limestone 
Cuesta plains in the eastern third. The area is not 
characterized by significant mineral deposits, exclusive 
of fuels. Small deposits of limestone and dolomite are 
located near Ponca City. None of these features are 
known to be associated with increased levels of background 
radioactivity or other items of carcinogenic potential. 
Vegetation is primarily tall grass, prairie type with 
Black Jack forest along rivers.
There are two accredited hospitals in Kay County, 
one in Ponca City and one in Blackwell, as well as a num­
ber of nonaccredited hospitals. As of January, 1966, there 
were 44 practicing physicians in the county, 5 of whom 
were in practice outside of the two major population cen­
ters. A health department employing a full-time director 
is in existence.
Washington County is located in northern Oklahoma, 
about 150 miles north of Oklahoma City. The county has an 
area of 425 square miles and had a 1960 population of 
42,348 (1965 estimate: 43,033), 40,348 of which were
white, and 2,000 non-white. The median age of the white 
population was 29.9 years and that of the non-white popu­
lation was 26.7 years. The one major population center of 
the county is Bartlesville, a city of 30,000. The
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remainder of the population is fairly uniformly distrib­
uted among several small communities and the surrounding 
rural area. The economy of the area is quite dependent 
upon the petroleum industry, although there are no large 
refineries in the immediate area. There is a large cement 
plant and a zinc smelter in the Bartlesville area. The 
economy is also supported by agricultural activity.
Vegetation in the western half of the county is 
Post Oak-Black Jack forest; in the eastern half it is tall 
grass, prairie type. The county lies entirely within a 
major oil and gas producing area. It is characterized by 
surface rock strata of the Upper Pennsylvanian. The 
topography is described principally as Claremore Cuesta 
Plains, with eastern Sandstone Cuesta Plains in the 
extreme west. The area is not characterized by great min­
eral deposits, excepting fuels. A belt of limestone and 
dolomite crosses the county running from southwest to 
northeast near Bartlesville. None of these geological 
features is thought to be associated with elevated back­
ground radioactivity or other items of carcinogenic 
potential.
There are two accredited hospitals in the county, 
both located in Bartlesville. There are a small number of 
nonaccredited facilities. In January, 1966, there were 
51 physicians in practice in the county, 3 practicing out­
side of Bartlesville. There was no health department in
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existence in Washington County.
Ottawa County is located in extreme northeast 
Oklahoma, 190 miles from Oklahoma City. The county has 
an area of 461 square miles and had a 1960 population of 
28,301 (1965 estimate: 30,901), consisting of 27,079
whites and 1,222 non-whites. The median age of the white 
population was 32.6 years and that of the non-white,
27.4 years. Miami, a city of 12,869, is the major popu­
lation center. The remaining population resides in a 
number of small communities and the surrounding rural 
areas. The economy of the county is dependent upon exten­
sive mining and ore processing operations, and upon agri­
culture .
Ottawa County is characterized by vegetation of 
the tall grass, prairie type, with the eastern third pre­
dominated by oak-hickory forest type. The county is 
characterized by rock strata of the Mississippian and 
Middle Pennsylvanian. The topography is described mostly 
as Neosho Lowland, with a small area of Ozark Plateau in 
the southeastern part. The area is characterized by 
extensive deposits of limestone and dolomite, but is not 
underlain by fossil fuels. There are extensive deposits 
of lead and zinc in the northern third of the county. 
Certain of these features, namely the metallic deposits, 
have been associated with excessive mortality from
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malignant diseases; but they have seldom been found to be 
associated with increased levels of radioactivity.
One accredited hospital in Miami, and a few small, 
nonaccredited hospitals serve this county. In 1966 there 
were 14 physicians in practice in the county, three of whom 
were located outside of Miami. The county has a local 
health department in full-time operation.
Rogers County is located in northeast Oklahoma 
about 125 miles northeast of Oklahoma City. The county 
has an area of 732 square miles and had a 1960 population 
of 20,614 (1965 estimate: 21,682), 19,398 of whom were
white, and 1,216 non-white. The median age of the white 
population was 30.8 years, and that of the non-white popu­
lation was 26.9 years. The one major population center is 
Claremore, a city of 6,639. The remainder of the popula­
tion is essentially rural or semi-rural. The economy of 
the area is primarily agricultural with some petroleum 
and coal mining.
The Oklahoma Geological Survey indicates Rogers 
County lies almost entirely within a belt of coal and oil 
that runs north and south in northeastern Oklahoma. The 
county is characterized by surface rock strata of the 
Middle Pennsylvanian. A small area of Upper Pennsylva­
nian is found in the extreme northwest, and an even 
smaller area of Quaternary is located in the southern 
section. The topography is described as Claremore Cuesta
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Plains, except for the extreme southeast corner which is 
Neosho Lowland. The area is also characterized by a large 
vein of limestone and dolomite running from southwest to 
northeast across the northwestern part of the county. No 
other mineral deposits, exclusive of fossil fuels, are 
noted. None of these features are thought to be associ­
ated with increased levels of background radioactivity, 
or other features having carcinogenic potential. Vegeta­
tion is the tall grass, prairie type, with belts of Post 
Oak-Black Jack forest.
There is one accredited hospital in Rogers County, 
located in Claremore. As of January 1, 1966, there were 
six physicians in practice in the county; five of these 
were practicing in Claremore. A health department in 
full-time operation is located in the county.
Stephens County is located in south-central Okla­
homa, about 85 miles south-southwest of Oklahoma City.
The county has an area of 890 square miles and had a 1960 
population of 37,990 (1965 estimate: 38,401), 36,985 of
whom were white, and 1,005 non-white. The median age of 
the white population was 31.2 years, and the non-white,
23.1 years. The major population center is Duncan, a city 
of 20,009. The remaining population is distributed 
throughout the surrounding smaller communities and rural 
areas. The economy of the area is greatly dependent upon 
agriculture with supplements from the petroleum industry
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and light manufacturing.
Much of Stephens County lies within an area of 
oil and gas production. The county is characterized by 
surface rock strata of the Middle and Lower Permian. The 
topography is described as Central Red-bed Plains, with a 
small area of Western Sandstone Hills in the extreme 
northern part of the county. The area is not character­
ized by significant mineral deposits, exclusive of fuels. 
None of the above features are known to be associated with 
increased levels of background radioactivity or other 
characteristics of carcinogenic potential. Vegetation is 
half tall grass, prairie type, and half Post Oak-Black 
Jack forest.
There are two accredited hospitals in Stephens 
County, both in Duncan. There is also a smaller non­
accredited hospital in Duncan. As of January 1, 1965, 
there were 17 physicians in practice in Stephens County.
A full-time health department is in operation in the 
county.
Carter County is located in southern Oklahoma, 
immediately adjacent to Stephens County, and about 100 
miles south of Oklahoma City. The county has an area of 
829 square miles and had a 1960 population of 39,044 (1965 
estimate: 38,288), 35,010 white, and 4,034 non-white.
The median age of the white population was 33.1 years, the 
non-white, 25.2 years. The major population center is
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Ardmore, a city of 20,184. The remainder of the popula­
tion is fairly uniformly distributed throughout neighbor­
ing small communities and the surrounding rural area. The 
economy of the area is a combination of agriculture, rock 
asphalt mining, petroleum, and light manufacturing.
Carter County lies astride a belt of oil and gas 
bearing strata that extends southeast to the Red River.
The county is characterized by surface rock strata of the 
Lower Permian in the west. Lower Cretaceous in the south 
and southeast, and a complex of Lower, Middle and Upper 
Pennsylvanian, Mississippian, Ordovician, Devonian and Sil- 
vanian, and Cambrian stretching across the hilly northern 
part of the county. The topography is described as Central 
Red-bed Plains in the west, Dissected Coastal Plain in the 
extreme south and southeast, Ardmore Basin in the east 
central part of the county, and Arbuckle Hills in the 
extreme north. The area is not characterized by great 
mineral deposits, excluding fuels, but does possess a small 
vein of limestone and dolomite in the south and far north, 
and some glass sand in the hills in the north. None of 
these features have been solidly associated with increased 
levels of radioactivity or other characteristics of carci­
nogenic potential. Vegetation is two-thirds Post Oak-Black 
Jack forest and one-third tall grass, prairie type.
There is one accredited hospital in Carter County, 
located in Ardmore. There are two smaller, as yet
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un-accredited, facilities there. As of January 1, 1965, 
there were 38 physicians in practice in the county; 35 of 
these were in practice in Ardmore. There is a full-time 
health department in operation in Carter County.
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Kay Cluster 944 48,588 2484 2 44 Petroleum-
Farming
Washington Control 425 40,348 2000 2 51 Petroleum-
Farming
Ottawa Cluster 461 27,079 1222 1 14 Mining-
Farming
Rogers Control 732 19,398 1216 1 6 Mining-
Farming
Stephens Cluster 890 36,985 1005 2 17 Petroleum-
Farming
Carter Control 829 35,010 4034 1 38 Petroleum-
Farming
N3
( j J
